Yiqiang Xie

889 total citations · 1 hit paper
14 papers, 531 citations indexed

About

Yiqiang Xie is a scholar working on Molecular Biology, Clinical Biochemistry and Complementary and alternative medicine. According to data from OpenAlex, Yiqiang Xie has authored 14 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Clinical Biochemistry and 2 papers in Complementary and alternative medicine. Recurrent topics in Yiqiang Xie's work include Metabolomics and Mass Spectrometry Studies (9 papers), Single-cell and spatial transcriptomics (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yiqiang Xie is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Single-cell and spatial transcriptomics (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yiqiang Xie collaborates with scholars based in China. Yiqiang Xie's co-authors include Shi Qiu, Aihua Zhang, Songqi Tang, Ying Cai, Chunsheng Lin, Hong Yao, Sifan Guo, Qiang Yang, Zhibo Wang and Qiang Yang and has published in prestigious journals such as Frontiers in Microbiology, Trends in Endocrinology and Metabolism and Signal Transduction and Targeted Therapy.

In The Last Decade

Yiqiang Xie

13 papers receiving 527 citations

Hit Papers

Small molecule metabolites: discovery of biomarkers and t... 2023 2026 2024 2025 2023 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiqiang Xie China 7 313 58 51 51 45 14 531
Kyung Mi Kim South Korea 12 375 1.2× 51 0.9× 101 2.0× 36 0.7× 35 0.8× 20 596
Reem Alshaman Saudi Arabia 16 244 0.8× 34 0.6× 29 0.6× 40 0.8× 36 0.8× 42 558
Kodihalli C. Ravindra United States 13 293 0.9× 68 1.2× 51 1.0× 96 1.9× 25 0.6× 22 699
Lina A. Dahabiyeh Jordan 15 288 0.9× 74 1.3× 45 0.9× 33 0.6× 14 0.3× 56 589
Guanwei Fan China 13 330 1.1× 70 1.2× 43 0.8× 30 0.6× 107 2.4× 31 732
Rui‐Jia Fu China 14 349 1.1× 37 0.6× 75 1.5× 37 0.7× 131 2.9× 58 720
Renshi Li China 13 213 0.7× 55 0.9× 31 0.6× 53 1.0× 53 1.2× 47 621
Ran Liu China 13 243 0.8× 26 0.4× 45 0.9× 16 0.3× 45 1.0× 33 417
Songqi Tang China 13 433 1.4× 109 1.9× 121 2.4× 58 1.1× 75 1.7× 31 847
Baogang Xie China 14 366 1.2× 81 1.4× 33 0.6× 63 1.2× 99 2.2× 48 744

Countries citing papers authored by Yiqiang Xie

Since Specialization
Citations

This map shows the geographic impact of Yiqiang Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiqiang Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiqiang Xie more than expected).

Fields of papers citing papers by Yiqiang Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiqiang Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiqiang Xie. The network helps show where Yiqiang Xie may publish in the future.

Co-authorship network of co-authors of Yiqiang Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yiqiang Xie. A scholar is included among the top collaborators of Yiqiang Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiqiang Xie. Yiqiang Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
3.
Qiu, Shi, Sifan Guo, Dandan Xie, et al.. (2025). Metabolite‐Guided Acetylation Therapy: Astragaloside IV Reverses Diabetic Nephropathy via Gna13‐Driven Purine Metabolic Reprogramming. Food Frontiers. 6(6). 2961–2974. 4 indexed citations
5.
Qiu, Shi, Sifan Guo, Dandan Xie, et al.. (2025). Single cell sequencing and spatial multiomics of diabetic kidney segmentation insights zonation-specific therapeutic metabolic pathways. PubMed. 4(3). 100252–100252. 9 indexed citations
7.
Guo, Sifan, Ying Cai, Qiang Yang, et al.. (2024). Decoding active compounds and molecular targets of herbal medicine by high-throughput metabolomics technology: A systematic review. Bioorganic Chemistry. 144. 107090–107090. 10 indexed citations
8.
Qiu, Shi, Zhibo Wang, Qiang Yang, et al.. (2023). Integrative multi-omics reveals the metabolic and functional diversity of microbiomes in the gut microenvironment. Frontiers in Microbiology. 14. 1168239–1168239. 6 indexed citations
9.
Guo, Sifan, Shi Qiu, Ying Cai, et al.. (2023). Mass spectrometry-based metabolomics for discovering active ingredients and exploring action mechanism of herbal medicine. Frontiers in Chemistry. 11. 1142287–1142287. 21 indexed citations
10.
Qiu, Shi, Ying Cai, Hong Yao, et al.. (2023). Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal Transduction and Targeted Therapy. 8(1). 132–132. 429 indexed citations breakdown →
11.
Cai, Ying, et al.. (2023). Critical roles of functional molecule metabolites. Frontiers in Molecular Biosciences. 10. 1119588–1119588. 9 indexed citations
12.
Qiu, Shi, Sifan Guo, Qiang Yang, et al.. (2023). Innovation in identifying metabolites from complex metabolome—Highlights of recent analytical platforms and protocols. Frontiers in Chemistry. 11. 1129717–1129717. 11 indexed citations
13.
Cai, Ying, Zhibo Wang, Sifan Guo, et al.. (2023). Detection, mechanisms, and therapeutic implications of oncometabolites. Trends in Endocrinology and Metabolism. 34(12). 849–861. 19 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026